Earnings Are Strong. Chips Are Getting Punished for It.

The S&P closed modestly lower. The Nasdaq fell roughly 1%. The Dow gained, carried almost entirely by UnitedHealth (UNH). Eight of eleven S&P sectors finished green. The equal-weight S&P ETF rose. The index fell.

The pattern is consistent now. Strong earnings. Diverging tape. Real economy names working. AI hardware names bleeding through their own good prints. Retail sales came in as expected at 0.2%. Jobless claims fell to 208,000, well below the 218,000 estimate. The economy is holding. The chip re-rating is happening separately.

TQ Trade Implication

This is not a bad economy story. The data is clean. This is an AI hardware valuation story working through its own momentum. Own healthcare, industrials, and financials through the re-rating. Reduce chip exposure until the valuation compression stabilizes.

TSMC Beat Estimates. Then It Raised Capex 20%. That Is Why Chips Fell.

TSMC (TSM) posted its fifth straight quarter of record earnings, with gross margin at a record 67.7%. The beat was clean. Then the company raised full-year capital spending to $60-64 billion from $52-56 billion, a roughly 20% increase. It also announced an additional $100 billion investment in Arizona.

That capex number is what the market reacted to. Not the beat. The market spent last week punishing IBM, Dell, and enterprise software for spending too much and earning too little. TSMC just told investors it is spending more than expected. That is the same framing, even though TSMC is spending on capacity that actually has buyers.

Goldman's prime brokerage unit noted hedge funds cut their net AI basket exposure to its lowest level this year. That is not a fundamental call. It is positioning. After doubling in a quarter, profits get locked.

TQ Execution Bias

Hedge fund de-grossing is mechanical and temporary. TSMC's capex raise is a demand confirmation, not a warning. The re-rating creates a better entry for patient holders. Own TSMC through the de-grossing, not around it.

UnitedHealth Earned $6.38 Per Share Against $4.90 Expected. Managed Care Is Fine.

UnitedHealth (UNH) surged roughly 4% after reporting adjusted earnings of $6.38 per share versus $4.90 expected. Revenue beat. Full-year guidance was raised. The company confirmed its Medicaid business is stable and growing.

Yesterday Elevance Health (ELV) fell sharply after saying it would exit several Medicaid markets. The entire managed care sector sold off with it. The question was whether Medicaid was a company problem or a sector problem. UnitedHealth just answered it. It is an Elevance problem.

That distinction matters for the stocks still to report. Centene (CNC) and Molina (MOH) both report soon. A sector problem meant both would guide lower. A company problem means UnitedHealth's scale absorbed what Elevance could not. Scale wins managed care cycles. It always has.

TQ Execution Bias

Own UnitedHealth and the larger managed care operators into the rest of reporting season. The Elevance discount was a gift. The sector is not broken. One company decided exit was cheaper than absorption.

The Philly Fed Hit 41.4. The Economy Is Not Slowing.

The Philadelphia Federal Reserve's manufacturing index surged to 41.4 for July, up 31 points from the prior reading and far above the 9.8 estimate. It is the highest reading since November 2021. The New York Fed's services gauge posted its first positive reading in nearly two years.

Both prints in the same session say the same thing. US manufacturing and services are expanding faster than any model predicted. This is the economy Warsh described: solid, with a resilient labor market and above-target inflation. It is also the economy that makes September's rate decision genuinely uncertain.

Jobless claims at 208,000 reinforced it. The consumer is spending. Companies are hiring. The Philly reading suggests factories are running hot. That is not a rate cut setup. It is barely a hold setup.

TQ Edge Setup

The Philly reading confirms what the banks told us this week. The economy is strong. The risk is not recession — it is that September becomes a live meeting regardless of what the chip tape says. Short duration exposure holds until the July 29th statement resolves it.

• South Korea banned new single-stock leveraged ETFs after SK Hynix swung more than 5% in eight of July's twelve trading sessions. South Korea just admitted its own retail investors are the volatility. Removing the leverage tool narrows the swing range. That is quietly positive for the underlying stocks.
• Eli Lilly (LLY) acquired AtaiBeckley for $2.8 billion, getting MDMA-based and DMT-based treatments for depression into its pipeline. Lilly is flush with GLP-1 cash and is diversifying fast. AtaiBeckley surged roughly 34%. This is Lilly's second major acquisition this year and both have been in categories far outside its core.
• Nvidia (NVDA) unveiled Cosmos 3 Edge, a new AI model designed to help robots perceive and navigate physical environments in real time. Nvidia is building the software layer on top of its hardware. If robots run on Cosmos the same way data centers run on CUDA, the moat doubles.
• United Airlines (UAL) guided below expectations after the close, citing $6 billion in added fuel costs for the year. Q2 beat on earnings but Q3 guidance came in well below estimates. The airline recovery story has a ceiling and WTI near $79 is sitting on top of it.

TSMC beat and raised capex.

Chips sold off. UnitedHealth proved managed care is intact. The Philly Fed hit a five-year high. The economy is strong. The AI hardware trade is being repriced. Both are true at the same time and the market is fine with that contradiction as long as the earnings keep coming.

Netflix reports after the close. Ad-supported tier growth is the only number that matters. The stock is down roughly 20% this year. A strong ad revenue quarter changes the narrative before the weekend. A weak one confirms the market was right to sell. Both scenarios land before tomorrow morning.